Both trials achieved statistical significance for the primary objective with Verrica’s VP-102, a candidate for molluscum contagiosum.
The post Verrica Releases Positive Phase 3 Results appeared first on Investing News Network.
Original Article: Verrica Releases Positive Phase 3 Results